CLC Genomics Workbench Software Maintenance and License Renewal

A SOLE SOURCE CONTRACT Title: CLC Genomics Workbench Software Maintenance and License Renewal Notice ID (POTS): 26-005973 (PSC): 7A21 – IT and Telecom Business Application Software NAICS Code: 513210 – Software Publishers

Place of Performance: National Institutes of Health Clinical Center Bethesda, MD 20892 This Notice of Intent (NOI) is issued for informational purposes only and does not constitute a Request for Quotations (RFQ). The Government does not intend to solicit competitive quotations for this requirement. The National Institutes of Health (NIH), Clinical Center, (OALM), intends to award a sole-source, firm-fixed-price purchase order to QIAGEN LLC, 19300 Germantown Road, Germantown, Maryland 20874-1415, for the annual maintenance and license renewal of the CLC Genomics Workbench software suite, including associated server maintenance and software modules required to support clinical genomic analysis. The anticipated

period of performance is from August 29, 2026, to August 28, 2027. The following items are required for this procurement: Product Name/Product Code/ Quantity CLC Genomics Server Execution Node/832633/3 CLC Genomics Server/832630/1 CLC Genomics Workbench CL/832609/3

Background The Department of Laboratory Medicine (DLM) relies on the CLC Genomics Workbench to support molecular diagnostics, bioinformatics analysis of next-generation sequencing (NGS) and Sanger sequencing data, and validated clinical workflows for human, mouse, and microbial genomes. The software provides integrated analysis tools that are essential for patient testing, research, and laboratory operations. Sole Source Rationale QIAGEN LLC is the exclusive provider of the CLC Genomics Workbench software and associated maintenance services. The existing software has been validated within DLM's clinical laboratory environment. Replacing the software with an alternate product would require extensive revalidation of laboratory workflows, increase costs, interrupt clinical operations, and could delay patient diagnosis and treatment. Authority This acquisition is being conducted pursuant to FAR 13.106-1(b)(1), Soliciting from a Single Source. Under this authority, the

Contracting Officer may solicit from a single source when only one source is reasonably available to satisfy the Government's

requirements. Acquisitions conducted under FAR Part 13 are exempt from the competition